Cholesterol Efflux Mechanisms in Lipid Metabolism

Cholesterol efflux is a fundamental aspect of lipid metabolism that safeguards cellular and systemic homeostasis by exporting excess cholesterol from peripheral tissues to the liver for excretion. In mammalian cells, efflux proceeds via passive mechanisms such as aqueous diffusion and facilitated diffusion through scavenger receptor class B type I, and active pathways mediated primarily by ATP-binding cassette transporters A1 and G1. The ABCA1 transporter orchestrates the transfer of free cholesterol and phospholipids to lipid-poor apolipoprotein A-I, initiating the biogenesis of nascent high-density lipoprotein particles. ABCG1 complements this process by promoting cholesterol efflux to mature HDL. Intracellular cholesterol trafficking, modulated by membrane contact sites and lipid transfer proteins, ensures a supply of substrate cholesterol to transporters at the plasma membrane. Nuclear receptors of the liver X receptor family transactivate genes governing efflux pathways, integrating sterol sensing with transcriptional control. Dysregulation of these mechanisms contributes to foam cell formation in arterial macrophages and underpins atherogenesis. Emerging insights into post-translational regulation, microRNA networks and inflammatory modulators have broadened our understanding and opened avenues for therapeutic modulation of reverse cholesterol transport and cardiovascular risk reduction.

Research from Nature Portfolio

Recent studies have elucidated the role of the AIM2 inflammatory sensor in modulating cholesterol efflux in macrophages. Bioinformatic analysis of atherosclerotic gene networks, combined with in vitro foam cell models, revealed that AIM2 expression correlates inversely with ABCA1 levels. Over-expression of AIM2 in lipid-loaded macrophages inhibited cholesterol efflux, increased intracellular cholesterol accumulation and amplified oxidative stress and pro-inflammatory cytokine release. Conversely, silencing AIM2 restored ABCA1 expression, improved efflux capacity and attenuated foam cell formation. These findings identify AIM2 as a negative regulator of the early steps in reverse cholesterol transport and suggest its inhibition as a potential strategy to curb plaque development and promote lipid homeostasis.

Cholesterol Efflux Mechanisms in Lipid Metabolism publication trend

The graph below shows the total number of articles in cholesterol efflux mechanisms in lipid metabolism across all publications each year (not limited to Nature Index journals).

Technical terms

Reverse cholesterol transport: The multi-step process by which excess cholesterol is exported from peripheral cells to the liver for elimination.

ATP-binding cassette transporter A1 (ABCA1): A membrane protein that exports cholesterol and phospholipids to lipid-poor apolipoprotein A-I, initiating HDL formation.

High-density lipoprotein (HDL): A class of lipoprotein particles that transport cholesterol from tissues back to the liver.

Foam cell: A lipid-laden macrophage found in atherosclerotic plaques, formed when cholesterol efflux is impaired.

microRNA-33: A small non-coding RNA that downregulates genes involved in cholesterol efflux and HDL metabolism.

AMP-activated protein kinase (AMPK): A kinase that senses cellular energy status and can modulate lipid transport proteins.

Calpain: A calcium-activated protease that can degrade ABCA1, reducing its stability and cholesterol efflux capacity.

References

1. Is microRNA-33 an Appropriate Target in the Treatment of Atherosclerosis?. Nutrients (2023).
2. MP Allosterically Activates AMPK to Enhance ABCA1 Stability by Retarding the Calpain-Mediated Degradation Pathway. International Journal of Molecular Sciences (2023).
3. Inflammatory corpuscle AIM2 facilitates macrophage foam cell formation by inhibiting cholesterol efflux protein ABCA1. Scientific Reports (2024).
4. Intracellular and Plasma Membrane Events in Cholesterol Transport and Homeostasis. Journal of Lipids (2018).
5. Molecular Mechanisms of Cellular Cholesterol Efflux*. Journal of Biological Chemistry (2014).
6. Sterol-dependent Transactivation of theABC1 Promoter by the Liver X Receptor/Retinoid X Receptor*. Journal of Biological Chemistry (2000).
7. The roles of different pathways in the release of cholesterol from macrophages. Journal of Lipid Research (2007).